Screener
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Dolby Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:45 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001308547-26-000010
| Line item | Fiscal Quarter Ended / March 27,2026 | Fiscal Quarter Ended / March 28,2025 | Fiscal Year-To-Date Ended / March 27,2026 | Fiscal Year-To-Date Ended / March 28,2025 |
|---|---|---|---|---|
| Total cost of revenue | 44,731 | 35,837 | 87,939 | 76,611 |
| Gross profit | 350,899 | 333,724 | 654,397 | 649,949 |
| Operating expenses: | ||||
| Research and development | 63,651 | 61,707 | 132,728 | 128,345 |
| Sales and marketing | 96,163 | 89,629 | 187,715 | 184,028 |
| General and administrative | 75,955 | 70,415 | 146,198 | 140,507 |
| Restructuring charges | 2,184 | 4,210 | 12,650 | 9,426 |
| Total operating expenses | 237,953 | 225,961 | 479,291 | 462,306 |
ITEM 1. UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Dolby Laboratories, Inc.'s R&D?
- Dolby Laboratories, Inc. (DLB) reported R&D of $63.65M in Q1 2026.
- How has Dolby Laboratories, Inc.'s R&D changed year-over-year?
- Dolby Laboratories, Inc.'s R&D increased by 3.2% year-over-year, from $61.71M to $63.65M.
- What is the long-term trend for Dolby Laboratories, Inc.'s R&D?
- Over 4 years (2021 to 2025), Dolby Laboratories, Inc.'s R&D has grown at a 0.8% compound annual growth rate (CAGR), from $253.64M to $261.79M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Dolby Laboratories, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude